Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
- 50mg-bottle-label - bottle label 01
- label - bottle label 02
- 150mg-bottle-label - bottle label 03
- clcr - clcr
- figure1 - pregabalin 01
- figure2 - pregabalin 02
- figure3 - pregabalin 03
- figure4 - pregabalin 04
- figure5 - pregabalin 05
- figure6 - pregabalin 06
- figure7 - pregabalin 07
- figure8 - pregabalin 08
- figure9 - pregabalin 09
- figure10 - pregabalin 10
- figure11 - pregabalin 11
- pregabalin-structure - pregabalin structure
Product Label Images
The following 16 images provide visual information about the product associated with Pregabalin NDC 76420-221 by Asclemed Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
50mg-bottle-label - bottle label 01
This is a pharmaceutical document that provides information about Pregabalm Capsule, 50 mg, and its packaging. There are details about the product's NDC (National Drug Code), quantity, manufacturer, source, and lot number. However, the document appears to be incomplete and contains many errors as it is a combination of different sections, making it difficult to understand.*
label - bottle label 02
150mg-bottle-label - bottle label 03
clcr - clcr
This is a formula for estimating the creatinine clearance (CLCr) of a patient. The CLCr value is calculated by multiplying the age of the patient in years (represented by the number 140) by the weight of the patient in kilograms, and then multiplying the result by 7 times the level of serum creatinine measured in mg/dL. For female patients, the final result is adjusted by multiplying by 0.85.*
figure1 - pregabalin 01
figure2 - pregabalin 02
Percent of Patients Improved is a measure of how many patients have shown improvement from their baseline, as denoted by the percent improvement score denoted as "iP". However, the text is not very clear and may be incomplete.*
figure3 - pregabalin 03
Percentage improvement in pain from baseline for two different treatments: Fragatalin and Fragaeain. Fragatalin is taken 3 times per day, while Fragaeain is taken either 3 times per day at a 120mg dose or twice per day at a 75mg dose. The also includes some random characters and a phone number which may not be relevant to the description.*
figure4 - pregabalin 04
figure5 - pregabalin 05
figure6 - pregabalin 06
figure7 - pregabalin 07
figure8 - pregabalin 08
figure9 - pregabalin 09
figure10 - pregabalin 10
figure11 - pregabalin 11
The text shows a chart or table indicating the percentage of subjects that have improved over a 16-week period. The improvement is measured from a baseline and the results are shown in increments of 10, from 0% to 100%.*
pregabalin-structure - pregabalin structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
